Logo
Advisory
Pharma Signal
About
Search
Log in
Subscribe
Request a discussion
Logo

PHARMA SIGNAL BY TALMEDICA

Read the shift before it's obvious.

A weekly look at the decisions, assumptions, and market changes shaping Medical Affairs, and what they mean for the leaders and teams doing the work.

Every Thursday by email. Free. Unsubscribe anytime.

RECENT ISSUES

What the market is signaling

Everyone Executed the Plan. Did We Solve the Right Problem?

When every function has a plan, who challenges the diagnosis?

Oct 22, 2026

Reach Isn't Impact. So What Should Field Medical Measure?

Only 40% say their organization measures MSL impact. The problem isn't the metrics. It's the theory behind them.

Oct 15, 2026

Before you lock your 2027 Medical Affairs plan

Four questions that should shape the model—not just the metrics.

Oct 1, 2026

A Field Team Is Not a Launch Plan

Where Medical Affairs launch readiness breaks—and what must connect before approval

Sep 24, 2026

The Leadership Transition We Don’t Prepare For

Getting the leadership role is one transition. Becoming the leader the role requires is another.

Sep 10, 2026

Why “Tell me about yourself” feels impossible after 10+ years in pharma

How to turn a 10-year archive into a clear, relevant introduction.

Sep 2, 2026

All issues →

Christine Ong, PharmD

WRITTEN BY

Christine Ong, PharmD

Founder of Talmedica, with 20+ years across drug development, regulatory strategy, and Medical Affairs and Field Medical leadership. Pharma Signal is also published on LinkedIn.

About Christine →

Interested in sponsoring Pharma Signal? →

Talmedica

Medical Affairs strategy, organizational design, and capabilities.

TALMEDICA

Advisory

About

Contact

PHARMA SIGNAL

Subscribe

Recent issues

Sponsorship inquiries

ADDITIONAL SERVICES

Technology and service provider advisory

LinkedIn


© 2026 Talmedica LLC. All rights reserved.

Editorial independence

Confidentiality

Privacy

Terms

© 2026 Talmedica.
beehiivPowered by beehiiv